Clinical trial
Bryostatin-1 in Treating Patients With Recurrent Non-Hodgkin's Lymphoma
NCT00002725 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00002725 |
|---|---|
| Title | Bryostatin-1 in Treating Patients With Recurrent Non-Hodgkin's Lymphoma |
| Official title | PHASE II EVALUATION OF BRYOSTATIN-1 (NSC 339555) IN NON-HODGKIN'S LYMPHOMA |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lymphoma |
| Intervention type | Drug |
| Interventions | bryostatin 1, chemotherapy |
| Enrollment | 35 |
| Start date | Aug 1, 1996 |
| Primary completion | Apr 1, 2000 |
| First posted | Jun 23, 2004 |
| Last update posted | Feb 5, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: